Clinical Trial Update: RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses [Phase 2]

View source ↗

Summary

Phase 2 clinical trial RE104 evaluating safety and efficacy for Adjustment Disorder in cancer and other medical illnesses; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adjustment Disorder

Drugs mentioned

• RE104

Snippet

Sponsor: Reunion Neuroscience Inc | Conditions: Adjustment Disorder | Phase 2 | Status: RECRUITING